Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.90
-1.06 (-5.06%)
Feb 21, 2025, 4:00 PM EST - Market closed
Arrowhead Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Net Income | -639.71 | -599.49 | -205.28 | -176.06 | -140.85 | -84.55 | Upgrade
|
| Depreciation & Amortization | 19.57 | 18.6 | 12.49 | 10.42 | 8.27 | 5.94 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.16 | 0.08 | - | 4.43 | -1.71 | -0.02 | Upgrade
|
| Stock-Based Compensation | 69.48 | 73.97 | 78.13 | 120.89 | 76.67 | 43.38 | Upgrade
|
| Other Operating Activities | 30.7 | 18.91 | 12.31 | 2.48 | 0.27 | 0.53 | Upgrade
|
| Change in Accounts Receivable | -2.5 | - | 1.41 | 8.85 | -9.41 | -0.18 | Upgrade
|
| Change in Accounts Payable | 10 | -5.54 | 33 | -6.59 | 2.63 | -0.82 | Upgrade
|
| Change in Unearned Revenue | - | -0.87 | -129.18 | -112.5 | 223.26 | -63.51 | Upgrade
|
| Change in Other Net Operating Assets | 21.03 | 31.49 | 43.23 | 11.95 | 12.19 | 3.44 | Upgrade
|
| Operating Cash Flow | -491.28 | -462.85 | -153.89 | -136.13 | 171.31 | -95.8 | Upgrade
|
| Capital Expenditures | -80.33 | -141.47 | -176.74 | -52.78 | -23.57 | -11.95 | Upgrade
|
| Investment in Securities | -327.67 | -278.6 | 80.58 | 47.36 | -118.11 | -228.83 | Upgrade
|
| Investing Cash Flow | -408 | -420.07 | -96.16 | -5.42 | -141.68 | -240.78 | Upgrade
|
| Long-Term Debt Issued | - | 392 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 392 | 392 | - | - | - | - | Upgrade
|
| Issuance of Common Stock | 432.02 | 431.65 | 3.05 | 5.19 | 11.31 | 257.95 | Upgrade
|
| Other Financing Activities | 66.87 | 46.87 | 250 | 60 | - | - | Upgrade
|
| Financing Cash Flow | 890.89 | 870.52 | 253.05 | 65.19 | 11.31 | 257.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4.07 | 4.2 | -0.12 | -0.07 | -0.09 | 0.41 | Upgrade
|
| Net Cash Flow | -4.33 | -8.21 | 2.89 | -76.43 | 40.85 | -78.22 | Upgrade
|
| Free Cash Flow | -571.61 | -604.32 | -330.63 | -188.91 | 147.75 | -107.75 | Upgrade
|
| Free Cash Flow Margin | -22864.48% | -17018.30% | -137.34% | -77.67% | 106.84% | -122.46% | Upgrade
|
| Free Cash Flow Per Share | -4.60 | -5.05 | -3.10 | -1.79 | 1.42 | -1.07 | Upgrade
|
| Cash Income Tax Paid | 2.76 | 3.74 | - | 0 | 0 | -0.1 | Upgrade
|
| Levered Free Cash Flow | -382.8 | -440.13 | -251.42 | -60.64 | 63 | -78.67 | Upgrade
|
| Unlevered Free Cash Flow | -352.41 | -419.91 | -239.96 | -60.64 | 63 | -78.67 | Upgrade
|
| Change in Net Working Capital | -30.09 | -4.67 | 25.72 | 27.61 | -94.77 | 57.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.